No Data
No Data
TuHURA Biosciences Shares Are Trading Higher After the Company Announced It Acquired Kineta.
12 Health Care Stocks Moving In Wednesday's After-Market Session
TuHURA Biosciences Expands Board With New Appointment
TuHURA Biosciences Appoints Craig Tendler to Board of Directors
TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference
H.C. Wainwright Initiates TuHURA Biosciences(HURA.US) With Buy Rating, Announces Target Price $13